IGNE - Igene Biotechnology, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.08M
Enterprise Value 3974.41k
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)225.32
Price/Book (mrq)N/A
Enterprise Value/Revenue 3202.83
Enterprise Value/EBITDA 6-2.28

Trading Information

Stock Price History

Beta (3Y Monthly) 1.54
52-Week Change 3-19.00%
S&P500 52-Week Change 32.99%
52 Week High 30.0009
52 Week Low 30.0002
50-Day Moving Average 30.0004
200-Day Moving Average 30.0004

Share Statistics

Avg Vol (3 month) 3236.49k
Avg Vol (10 day) 344.69k
Shares Outstanding 51.57B
Float N/A
% Held by Insiders 10.00%
% Held by Institutions 10.53%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 44.10%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2009
Most Recent Quarter (mrq)Sep 30, 2010

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-12,422.32%

Management Effectiveness

Return on Assets (ttm)-8.21%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.8k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.02M
EBITDA -426.98k
Net Income Avi to Common (ttm)-2.37M
Diluted EPS (ttm)-0.0020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)269.29k
Total Cash Per Share (mrq)0
Total Debt (mrq)363.87k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.15
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.68M
Levered Free Cash Flow (ttm)-442.78k